CASI Pharmaceuticals
CASI
#9690
Rank
A$59.26 M
Marketcap
$3.83
Share price
-1.21%
Change (1 day)
-54.83%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$44.32 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$22.05 Million. In 2023 the company made an earning of -A$41.18 Million, an increase over its 2022 earnings that were of -A$58.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.32 Million7.61%
2023 -A$41.18 Million-29.55%
2022 -A$58.45 Million4.43%
2021 -A$55.97 Million-24.56%
2020 -A$74.19 Million4.74%
2019 -A$70.84 Million65.13%
2018 -A$42.9 Million155.07%
2017 -A$16.82 Million13.93%
2016 -A$14.77 Million31.18%
2015 -A$11.26 Million-72.5%
2014 -A$40.92 Million356.62%
2013 -A$8.97 Million-60.55%
2012 -A$22.72 Million218.41%
2011 -A$7.14 Million0.74%
2010 -A$7.09 Million-32.54%
2009 -A$10.5 Million-66.98%
2008 -A$31.79 Million-14.22%
2007 -A$37.06 Million7.04%
2006 -A$34.62 Million27.95%
2005 -A$27.06 Million4.51%
2004 -A$25.89 Million-15.84%
2003 -A$30.77 Million-55.29%
2002 -A$68.81 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$79.2 Million31.56%
1999 -A$60.2 Million145.56%
1998 -A$24.52 Million76.4%
1997 -A$13.9 Million36.92%
1996 -A$10.15 Million